About Hermansky-Pudlak syndrome due to BLOC-2 deficiency
Hermansky-Pudlak syndrome due to BLOC-2 deficiency is a rare disease catalogued by Orphanet (ORPHA:231512). It is associated with the HPS3, HPS5, HPS6 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hermansky-Pudlak syndrome due to BLOC-2 deficiency trials.
Search ClinicalTrials.gov for "Hermansky-Pudlak syndrome due to BLOC-2 deficiency" or filter by Orphanet code ORPHA:231512 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hermansky-Pudlak syndrome due to BLOC-2 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hermansky-Pudlak syndrome due to BLOC-2 deficiency. Updated daily.